» Articles » PMID: 25741458

Comparison of False Positive Rates for Screening Breast Magnetic Resonance Imaging (MRI) in High Risk Women Performed on Stacked Versus Alternating Schedules

Overview
Journal Springerplus
Date 2015 Mar 6
PMID 25741458
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Breast MRI added to mammography increases screening sensitivity for high-risk women but false-positive (FP) rates are higher and the optimal screening schedule for coordination with mammography is unclear. We compare rates of FP MRI when studies were performed on two different schedules.

Patients And Methods: High-risk women at the University of Vermont who had at least 1 MRI and 1 mammogram performed within one year between 2004-2012 were eligible for inclusion in this study. Screening was considered stacked if both studies were performed within 90 days and alternating if studies were 4-8 months apart. False positive was defined in one of three ways.

Results: 137 women had screening which met inclusion criteria and 371 MRIs were reviewed. The FP rates were similar for the two schedules when considering BI-RAD 4, 5, 0 or biopsy as a positive test. FP rates were significantly higher for the stacked schedule (18.2 vs. 10.2%, p = 0.026) when considering BI-RADS 3-4-5-0 as positive test, due to the elevated rate of BI-RADS 3 assessments among stacked exams.

Conclusion: False positive rates differ based on the type of exam (baseline or subsequent) and definition of positive but do not differ based on imaging schedule (stacked or alternating); suggesting that women and their providers may choose the imaging schedule they prefer. This is significant as a randomized clinical trial comparing the two schedules is not likely to be performed, given the high cost and large number of women needed for such a study.

Citing Articles

Implementation of a Novel Patient Decision Aid for Women with Elevated Breast Cancer Risk Who Are Considering MRI Screening: A Pilot Study.

Chu C, Smith C, Gorski J, Smolkin M, Zhao H, Jones R Ann Surg Oncol. 2023; 30(10):6152-6158.

PMID: 37505352 DOI: 10.1245/s10434-023-13901-w.


[MRI-Guided Breast Intervention: Biopsy and Needle Localization].

Park G, Lee J, Kang B, Kim S J Korean Soc Radiol. 2023; 84(2):345-360.

PMID: 37051391 PMC: 10083625. DOI: 10.3348/jksr.2022.0162.


Screening through Temperature and Thermal Pattern Analysis in DMBA - Induced Breast Cancer in Wistar Rats.

Poerbaningtyas E, Dradjat R, Endharti A, Sakti S, Widjajanto E J Biomed Phys Eng. 2021; 11(4):505-514.

PMID: 34458198 PMC: 8385218. DOI: 10.31661/jbpe.v0i0.1229.


Optimisation of an Electrochemical DNA Sensor for Measuring KRAS G12D and G13D Point Mutations in Different Tumour Types.

Attoye B, Baker M, Thomson F, Pou C, Corrigan D Biosensors (Basel). 2021; 11(2).

PMID: 33562505 PMC: 7914712. DOI: 10.3390/bios11020042.


Tuning the size and composition of manganese oxide nanoparticles through varying temperature ramp and aging time.

Martinez de la Torre C, Grossman J, Bobko A, Bennewitz M PLoS One. 2020; 15(9):e0239034.

PMID: 32946514 PMC: 7500698. DOI: 10.1371/journal.pone.0239034.


References
1.
Varas X, Leborgne J, Leborgne F, Mezzera J, Jaumandreu S, Leborgne F . Revisiting the mammographic follow-up of BI-RADS category 3 lesions. AJR Am J Roentgenol. 2002; 179(3):691-5. DOI: 10.2214/ajr.179.3.1790691. View

2.
Abramovici G, Mainiero M . Screening breast MR imaging: comparison of interpretation of baseline and annual follow-up studies. Radiology. 2011; 259(1):85-91. DOI: 10.1148/radiol.10101009. View

3.
Hendrick R, Smith R, Rutledge 3rd J, SMART C . Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr. 1997; (22):87-92. DOI: 10.1093/jncimono/1997.22.87. View

4.
Warner E, Hill K, Causer P, Plewes D, Jong R, Yaffe M . Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging. J Clin Oncol. 2011; 29(13):1664-9. PMC: 4874196. DOI: 10.1200/JCO.2009.27.0835. View

5.
Rosen E, Baker J, Soo M . Malignant lesions initially subjected to short-term mammographic follow-up. Radiology. 2002; 223(1):221-8. DOI: 10.1148/radiol.2231011355. View